Nano Software Services
Market Cap
₹140 Cr.
P/E
121.39
  • Jeevan Scientific
  • Vivo Bio Tech
  • Zenotech Labs.

FAQs on Jeevan Scientific Technology Ltd. Shareprice

Jeevan Scientific has given better returns compared to its competitors.
Jeevan Scientific has grown at ~10.4% over the last 8yrs while peers have grown at a median rate of 4.2%

Jeevan Scientific is expensive when considering the PE ratio, however latest EV/EBIDTA is < 3 yr avg EV/EBIDTA.
Latest PE of Jeevan Scientific is 121, while 3 year average PE is 79.96.
Also latest EV/EBITDA of Jeevan Scientific is 15.04 while 3yr average is 61.49.

Growth Table

  • Jeevan Scientific Technology Ltd.
  • Vivo Bio Tech
  • Zenotech Labs.

Balance Sheet

  • Jeevan Scientific Technology Ltd.
  • Vivo Bio Tech
  • Zenotech Labs.

Balance Sheet Snapshot

No data available.

Fund Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end

Profit & Loss

  • Jeevan Scientific Technology Ltd.
  • Vivo Bio Tech
  • Zenotech Labs.

Cash Flow

  • Jeevan Scientific Technology Ltd.
  • Vivo Bio Tech
  • Zenotech Labs.

Cash Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.

Ratios

= Dominant Factor
  • Jeevan Scientific Technology Ltd.
  • Vivo Bio Tech
  • Zenotech Labs.

Quarterly Results

  • Jeevan Scientific Technology Ltd.
  • Vivo Bio Tech
  • Zenotech Labs.

Reverse DCF

locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*

FAQs on Jeevan Scientific Technology Ltd. Financials

Balance sheet of Jeevan Scientific is strong.
It shouldn't have solvency or liquidity issues.

The net debt of Jeevan Scientific is decreasing.
Latest net debt of Jeevan Scientific is ₹7.65 Crs as of Mar-26.
This is less than Mar-25 when it was ₹14.84 Crs.

Yes, profit is increasing.
The profit of Jeevan Scientific is ₹1.05 Crs for TTM, ₹0.12 Crs for Mar 2025 and -₹1.3 Crs for Mar 2024.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Jeevan Scientific latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%

Companies resources are allocated to majorly productive assets like Plant & Machinery and unproductive assets like Accounts Receivable

Ideas Dashboard
Results
Timeline
Watchlist
Portfolio
Alerts
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech